0RA9
Abivax SA · LSE:0RA9
76.17 EUR−1.62 −2.09%
Abivax SA (LSE:0RA9) last traded at 76.17 EUR, down 2.09% on the day. Over the past year the stock is down 13.54%. Its 52-week range is 60.70 to 139.00. It is in the Health Technology sector (Pharmaceuticals: Other).
Key statistics
Open75.45
Day range75.35 – 76.17
52-week range60.70 – 139.00
Volume18.39 K
Average volume (10 days)2.98 K
Market cap (USD)7.45 B
EPS (TTM) (USD)−5.98
Dividend yield0.00%
Beta (1 year)1.11
Revenue (TTM) (USD)0
Employees69
Performance
−2.15%1 week
−9.32%1 month
−30.31%3 months
−29.99%6 months
−35.55%Year to date
−13.54%1 year
Technical reading
Strongly bearish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Abivax to Participate in Upcoming Fall Investor ConferencesEQS · 02 Nov 2026
- Abivax to Participate in Upcoming Fall Investor ConferencesGlobeNewswire · 02 Nov 2026
- Abivax Price Target Cut to $96.00/Share From $118.00 by WedbushDow Jones Newswires · 21 Oct 2026
- Abivax Price Target Maintained With a $175.00/Share by GuggenheimDow Jones Newswires · 20 Oct 2026
- Cedar Grove Capital Q3: Adds Zedcor, Auxly; exits MTY, ClearPointSeeking Alpha · 15 Oct 2026
- Seeking Alpha’s Quant Spotlight: Highest and lowest rated healthcare stocks ahead of Q3Seeking Alpha · 13 Oct 2026
- Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026EQS · 30 Sep 2026
- Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026GlobeNewswire · 30 Sep 2026
Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.